Clasado Biosciences, developer of the proprietary prebiotic ingredient Bimuno GOS, has announced a new distribution agreement with Cosmic Concord, the functional ingredient business unit of 3C Group, a prominent nutraceutical distributor and manufacturer in Thailand.
This strategic partnership grants Cosmic Concord exclusive distribution rights for Bimuno GOS and its direct to consumer (D2C) product, Bimuno Original in the Thailand market. This marks a significant step in expanding the presence of this acclaimed prebiotic ingredient in the rapidly emerging APAC health and nutrition sector. 3C Group has completed the product registration of Bimuno GOS in Thailand for both its powder and syrup formats with Bimuno Original to follow suit shortly.
According to recent market research conducted by intelligence firm Facts & Factors, the global prebiotic ingredient market is projected to experience a robust compound annual growth rate of 11.5% to 2028. The European and North American markets show immense potential for prebiotic growth, and the same is applicable for the Asian-Pacific (APAC) region, as consumers turn to gut health as a way of supporting their health and wellbeing.
Bimuno GOS stands out as the most extensively studied commercially available galactooligosaccharide. The ingredient has garnered recognition for its wide-ranging benefits in gastrointestinal, digestive, immune, and cognitive health, with its safety and efficacy supported by over 110 scientific publications, including more than 20 clinical trials.
David Mharakurwa, Sales Director APAC & MEA at Clasado Biosciences, said: "We are delighted to be working with 3C Group on bringing Bimuno GOS to the Thailand market. With their excellent local market position and extensive experience in science-backed functional solutions, we are confident that 3C Group is well-positioned to supply Bimuno GOS to the health and nutrition market across Thailand. Furthermore, this collaboration will allow us to showcase the remarkable scientific foundation that distinguishes Bimuno GOS from its competitors and highlight its unparalleled potential in supporting gut health in Thailand."
With prebiotics setting the stage for major global growth, we are thrilled to bring Bimuno GOS to formulators across Thailand
- Nuttapon Songpornprasert, CEO at 3C Group
Nuttapon Songpornprasert, CEO at 3C Group, said: "With prebiotics setting the stage for major global growth, we are thrilled to bring Bimuno GOS to formulators across Thailand, as well as supplying the Bimuno Original finished supplement – which is itself a great showcase of the prebiotic ingredient. Gut health awareness continues to rise, and consumers are increasingly focusing on nurturing the trillions of bacteria in their gut microbiome.
What sets Bimuno GOS apart is its ability to selectively nourish beneficial bacteria, such as Bifidobacteria, which play a crucial role in supporting overall health and wellbeing. Additionally, its effectiveness at a low dosage of just 1.37g per day gives it added versatility, making it ideal for a wide range of product applications. With our longstanding commitment to supplying specialised ingredients to the food and nutrition industries for more than 40 years, the addition of Bimuno GOS and Bimuno Original is a valuable enhancement to our science-backed product portfolio."
The 3C team will be attending FI Asia in Thailand, held at the Queen Sikrit National Convention Center in Bangkok between 20 – 22 September. The event, bringing together industry experts and thought leaders in the field of functional food and beverage ingredients, provides an opportunity to discover the latest industry innovations and trends. The 3C team will be showing the multi-award-winning prebiotic ingredient, Bimuno GOS, at stand M21.
Clasado Biosciences and 3C Group are confident that this partnership will not only generate interest for the science-backed prebiotic in the Thailand market, but also cater to the growing demand for advanced gastrointestinal, immune and cognitive health solutions in the wider APAC region.
By combining Clasado's leading prebiotic expertise with 3C Group's extensive distribution network and market insights, the companies aim to provide Thai nutraceutical businesses with the most scientifically supported prebiotic ingredient of its kind, alongside access to high-quality prebiotic product development.
